The Virosart® CPV filters are used in the biopharmaceutical industry to ensure the protection and purity of products by removing viruses from process fluids. Virosart® CPV product family is designed specifically to meet the diverse needs of monoclonal antibody applications, from laboratory research to large-scale manufacturing. They are designed to provide robust performance and high virus retention while maintaining product yield and process efficiency.
Key Features:
- Membrane Technology: Asymmetric Polyethersulfone (PES) Membrane: The PES membrane is engineered to process monoclonal antibodies and recombinant proteins.
- High Virus Retention: Achieves significant logarithmic reduction values for both enveloped and non-enveloped viruses, ensuring effective virus clearance across various operating conditions.
- Efficient Process Integration: Designed for seamless integration into existing single-use and stainless steel facilities, minimizing downtime and optimizing workflow.
- Regulatory Compliance: Manufactured under ISO 9001 certified Quality Management System and non-pyrogenic as per USP Bacterial Endotoxins standards.
- Versatile Device Formats: Available as cartridges and self-contained capsules.
- Integrity Testing: Reliable integrity testing using Sartocheck® technology. Furthermore, each unit is integrity tested (except non-IT tested version of Minisart®, see specifications) and complies with industry standards, ensuring reliability and performance.
- Operating Parameters:
Filtration pressure: Max. 5.0 bar (72.5 psi) at 20°C; 0.2 bar (2.9 psi) at 121°C.
Reversed filtration pressure: Max. 0.2 bar (2.9 psi) at 20°C.
Ordering Information:
- Cartridge Options: Multiple sizes; autoclavable and steamable.
- Maxicaps®: Self-contained, various sizes of different filtration areas.
- Midicaps® & Capsules: Self-contained, sanitary connectors for easy installation as well as hose barb for capsules.